Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Total Articles

4
(from Reference Citation Analysis)

Article PDFs (0)

Cited by > 0 (0)

Searched Name

Cardura

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Statistics

Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Category

Show more Refine

Number	Citation Analysis
1	Drugs for hypertension. THE MEDICAL LETTER ON DRUGS AND THERAPEUTICS 2024;66:81-88. [PMID: 38771738 DOI: 10.58347/tml.2024.1703a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2024] Abstract American College of Cardiology/American Heart Association (ACC/AHA) guidelines for treatment of hypertension were last published in 2018.1 Treatment of hypertensive urgencies and emergencies is not discussed here. Collapse Key Words ACE inhibitors ARBs Accupril Accuretic Aldactone Altace Atacand Avalide Avapro Azor Benicar Bystolic Cardizem Cardura CaroSpir Cartia Corgard Cozaar Dilt-XR Diovan Diuril Dyrenium Edarbi Edarbyclor Edecrin Epaned Exforge Hyzaar Inderal InnoPran Inspra Kapspargo Sprinkle Katerzia Lasix Lopressor Lotensin Lotrel Matzim Micardis Norvasc Prestalia Procardia Qbrelis Soaanz Sular Taztia Tekturna Tenoretic Tenormin Thalitone Tiadylt Tiazac Toprol Tribenzor Tryvio Vaseretic Vasotec Verelan Zestoretic Zestril acebutolol adverse effects aliskiren amiloride amlodipine aprocitentan atenolol azilsartan benazepril beta blockers betaxolol bisoprolol bumetanide candesartan captopril carvedilol chlorothiazide chlorthalidone clonidine diltiazem diuretics dosage doxazosin efficacy enalapril eplerenone eprosartan ethacrynic acid felodipine fosinopril furosemide guanfacine hydralazine hydrochlorothiazide hypertension indapamide irbesartan isradipine labetalol lisinopril losartan methyldopa metolazone metoprolol minoxidil moexipril nadolol nebivolol nicardipine nifedipine nisoldipine olmesartan perindopril pindolol prazosin pregnancy propranolol quinapril ramipril safety spironolactone telmisartan terazosin timolol torsemide trandolapril triamterene valsartan verapamil Collapse MESH Headings Humans Hypertension/drug therapy Hypertension/physiopathology Antihypertensive Agents/therapeutic use Antihypertensive Agents/adverse effects Antihypertensive Agents/administration & dosage Blood Pressure/drug effects Collapse Grants Collapse
2	A fixed-dose combination of finasteride and tadalafil (Entadfi) for BPH. THE MEDICAL LETTER ON DRUGS AND THERAPEUTICS 2022;64:e1-e2. [PMID: 36094555] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023] Abstract Collapse Key Words Avodart Cardura Cialis Entadfi Flomax Myrbetriq Proscar Vesicare adverse effects benign prostatic hyperplasia dosage doxazosin drug interactions dutasteride efficacy finasteride mirabegron safety solifenacin tadalafil tamsulosin Collapse MESH Headings Drug Therapy, Combination Finasteride/adverse effects Humans Male Prostatic Hyperplasia/drug therapy Tadalafil/adverse effects Collapse Grants Collapse
3	Drugs for benign prostatic hyperplasia. THE MEDICAL LETTER ON DRUGS AND THERAPEUTICS 2022;64:65-69. [PMID: 35471226] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023] Abstract Collapse Key Words Avodart Cardura Cialis Detrol Ditropan Entadfi Flomax Gemtesa Jalyn Myrbetriq Proscar Rapaflo Toviaz Uroxatral Vesicare adverse effects alfuzosin benign prostatic hyperplasia darifenacin dosage doxazosin drug interactions dutasteride efficacy fesoterodine finasteride herbals mirabegron oxybutynin safety silodosin solifenacin tadalafil tamsulosin terazosin tolterodine trospium vibegron Collapse MESH Headings Humans Male Prostatic Hyperplasia/diagnosis Prostatic Hyperplasia/drug therapy Risk Factors Collapse Grants Collapse
4	Drugs for hypertension. THE MEDICAL LETTER ON DRUGS AND THERAPEUTICS 2020;62:73-80. [PMID: 32555118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/11/2023] Abstract Collapse Key Words ACE inhibitors ARBs Accupril Accuretic Adalat Aldactone Altace Atacand Avalide Avapro Benicar Bystolic Calan Cardizem Cardura CaroSpir Cartia Catapres Coreg Corgard Cozaar Dilt-XR Diovan Diuril Dutoprol Dyrenium Edarbi Edarbyclor Edecrin Epaned Hyzaar Inderal InnoPran Inspra Kapspargo Sprinkle Katerzia Lasix Lopressor Lotensin Matzim Micardis Minipress Norvasc Prinivil Procardia Qbrelis Sular Taztia Tekturna Tenoretic Tenormin Tiadylt Tiazac Toprol Vaseretic Vasotec Verelan Zestoretic Zestril Ziac acebutolol adverse effects aliskiren amiloride amlodipine atenolol azilsartan benazapril beta blockers betaxolol bisoprolol bumetanide calcium-channel blockers candesartan captopril carvedilol chlorthalidone clonidine diltiazem diuretics dosage doxazosin efficacy enalapril eplerenone eprosartan ethacrynic acid felodipine fosinopril furosemide guanfacine hydralazine hydrochlorothiazide hypertension indapamide irbesartan isradipine labetalol lisinopril losartan methyldopa metolazone metoprolol minoxidil moexipril nadolol nebivolol nicardipine nifedipine nisoldipine olmesartan perindopril pindolol prazosin pregnancy propranolol quinapril ramipril safety spironolactone telmisartan terazosin timolol torsemide trandolapril triamterene valsartan verapamil Collapse MESH Headings Antihypertensive Agents/adverse effects Antihypertensive Agents/pharmacology Antihypertensive Agents/therapeutic use Blood Pressure/drug effects Humans Hypertension/drug therapy Hypertension/physiopathology Collapse Grants Collapse